SUMMARY. The stability of plasma parathyroid hormone-related protein (PTHrP) as measured by the Nichols Institute assay at room temperature was assessed over a period of 72 h in blood samples collected in protease inhibitor tubes and EDTA tubes at 0, 6, 24, 48 and 72 h from 10 patients with hypercalcaemia of malignancy. Mean plasma PTHrP concentrations in blood samples collected in protease inhibitor tubes remained stable for up to 48 h but had decreased by 10010 at 72 h. The mean EDTA plasma PTHrP at zero time was 67010 of the protease inhibitor tube value and this had fallen to 39010 at 72 h. The stability of parathyroid hormone (PTH) in separated blood samples was also assessed by collection into heparin and plain tubes as well as EDTA and protease inhibitor tubes. Serum PTH concentrations progressively declined throughout the 72 h study period although the zero time values were significantly higher than corresponding plasma PTH concentrations. Plasma PTH concentrations appeared to be stable when blood was collected in heparin, EDTA and protease inhibitor tubes during the 72 h period, except in one subject with markedly elevated plasma amylase activity.
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The application of sensitive assays for parathyroid hormone related protein (PTHrP) is increasing understanding of the role of this peptide in the pathogenesis of hypercalcaemia in malignant disease. [1] [2] [3] [4] Initial reports suggest that PTHrP is unstable in plasma and degrades rapidly at room temperature or 4°C unless blood is collected with protease inhibitors and plasma frozen rapidly. Storage of blood samples at room temperature collected in protease inhibitor tubes also appears to lead to rapid loss of PTHrp. 4 Intact parathyroid hormone (PTH), in contrast to PTHrP, appears to be stable in whole blood and serum for up to 6 h at room temperature in the absence of preservatives! although significant losses have been reported by 18 h even in the presence of aprotinin."
We report here a more extended study of the stability of PTHrP and PTH when stored at room Correspondence: Dr J A Nisbet.
temperature for up to 72 h in the presence and absence of protease inhibitors.
PATIENTS AND METHODS

Patients
PTHrP stability Blood was collected from 10 patients with hypercalcaemia of malignancy: breast carcinoma (3), renal cell adenocarcinoma (2), multiple myeloma (1), pancreatic carcinoma (1), lung carcinoma (I), metastatic carcinoma with unknown primary site (2).
PTH stability
Blood was collected from nine patients with primary hyperparathyroidism, diagnosed by demonstrating hypercalcaemia with inappropriately elevated PTH values: eight patients with chronic renal failure; eight healthy subjects; and three patients with acute pancreatitis (serum amylase activity between 4 and 14 times the upper limit of reference range).
Blood collection protocol PTHrP Ten millilitres venous blood was collected into heparinized tubes supplied by Nichols Institute Diagnostics Ltd (Newport, UK) and containing aprotinin (> 216 KIU/mL) and leupeptin (2' 5 /Lg/mL). These tubes were stored at -20°C until use. A further 10 mL blood was collected into EDTA Exetainer tubes (Labco Ltd, High Wycombe, UK), chilled, centrifuged at 4°C within 30 min and frozen within 60 min. Separated serum and EDT A plasma portions were kept at room temperature for 6, 24, 48, 72 hand then stored frozen until analysed. All samples from each patient were analysed in the same batch.
PTH
Thirty millilitres blood was collected and divided equally into tubes containing either protease inhibitors (Nichols Institute), EDTA, lithium heparin or no anticoagulant (Labco Ltd). Subsequent centrifugation, separation and storage was identical to the PTHrP protocol.
Methods
PTHrP was measured by the Allegro two site immunoradiometric assay kit (Nichols Institute). The assay uses two affinity purified polyclonal antibodies, one directed to the N-terminal 1-40 amino acid sequence and labelled with 1251 
RESULTS
PTHrP
The stability of plasma PTHrP at room temperature over 72 h is shown in Table 1 . The mean PTHrP value at zero time in the patients with hypercalcaemia of malignancy was 8·24 pmollL (range 2· 2-20' 7) in protease inhibitor tubes, and in EDTA tubes was 5·2pmollL (2'4-15'0). Samples collected in EDTA tubes gave significantly lower values than those in protease inhibitor tubes (P< 0,01) at all time periods.
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PTHrP over the 72 h period (P<0·05). The remaining eight patients individually showed no significant change in PTHrP (P>0·05).
Samples collected in EDTA showed a significant progressive decline in PTHrP concentration throughout the 72 h period (Table 1) .
PTH
Serum PTH values at zero time were slightly but significantly higher than plasma collected in heparin (P<O·Ol), EDTA (P<0'05) or protease inhibitor (P<O·OI) tubes (Table 2) . EDTA plasma PTH concentrations were significantly higher (P<0'05) than heparinized plasma.
PTH concentrations Samples collected in protease inhibitor, EDT A or heparin tubes gave similar PTH values which did not change significantly for up to 72 h storage at room temperature (P>0·05, Table 2 ).
In two patients with serum amylase activities four to five times the upper limit of normal, the stability of PTH was similar to that for the healthy subjects, i.e. serum PTH values decreased steadily throughout the 72 h period but plasma PTH (from heparinized, EDTA and protease inhibitor tubes) remained stable during the study period. However, in one patient where the amylase value was approximately 14 times the upper limit of normal, the PTH value had decreased by 50010 at 6 h not only in the serum tube but also in the heparin, EDTA and protease inhibitor tubes. At 24 h, PTH had decreased by 80% in all tubes and thereafter remained constant.
DISCUSSION
PTHrP assayed with the Nichols Institute reagents appears to be stable in separated plasma for up to 48 h when blood is collected in tubes containing protease inhibitors. Stability is better than that reported previously for samples
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collected in tubes with protease inhibitors where plasma PTHrP was only 42010 of the initial value at 24 h although at 4°C stability for 48 h was obtained.? Our data indicate that EDTA collection tubes are unsuitable for assay of this hormone and support the recommendation of Pandian et al. 3 that PTHrP is best stabilized when collected with aprotinin and leupeptin.
There have been several studies of the stability of PTHrP in either whole blood or in plasma, and some consistency is emerging. The majority of these reports relate to immunoradiometric assays which detect PTHrP 1-74 or 1-84. The peptide appears to be less stable in whole blood than in separated plasma when collected in the presence The increased losses of PTHrP in unseparated blood compared with plasma may be due to the presence of cell derived proteases against which the added antiproteases are relatively ineffective. It is possible that the greater thermostability of the present assay compared with that found by Pandian et al. 3 is related to the different antibody specificities of the two IRMAs. The antibodies used in the Pandian assay recognize PTHrPI-36 and PTHrP37-74 in contrast to the Nichols assay where PTHrPI-40 and PTHrP60-72 are recognized. Additional factors that could account for our findings include differences in the protease inhibitor concentrations, collection protocol;' and the histological type of malignancy." Intact PTH concentrations in serum progressively declined throughout the 72 h period. However, PTH was apparently stable in separated plasma when blood was collected in heparinized, EDTA and protease inhibitor tubes provided amylase as an index of proteolytic activity was normal or only slightly raised. With more severe pancreatitis it is likely that PTH is unstable even in the presence of protease inhibitors, a finding noted by Newman and Ashby in a single patient with pancreatitis" and in our study. Intact parathyroid hormone has been previously reported to be unstable in serum at room temperature. Ratcliffe et al. s found that PTH fell by 36% after 24 h. Newman and Ashby'' found a 14070 loss over the same time period, and PTH degradation was not prevented by addition of aprotinin to the samples. A progressive deterioration in serum PTH with decreases of 20% and 34% after 1 and 3 days, respectively, was also observed by Wood. s The increased susceptibility to degradation of PTH in serum compared to plasma may also be due to the presence of more cell-derived proteases in serum.
